China Medical Technologies (Beijing) has been developing IVD, ECLIA, FISH and SPR diagnostics since 1999 (first listed on Nasdaq, under “CMED” in 2005). Recently, it announced its FISH probe for the Philadelphia translocation defect involved in three major types of leukemia.  As others have discovered, China Medical senses the vast expansion of commercial diagnostics that comes with molecular medicine.   MORE